HIGHLIGHTS
- who: Simone M. Crivelli from the Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel, ER Maastricht, the Netherlands have published the research: CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease, in the Journal: (JOURNAL)
- what: The authors report that binds to APP modifies Aβ aggregation and Aβ neurotoxicity in vitro. The authors show that intracortical injection of mediating the expression of decreases levels of d18:1/16:0 and increases levels in the brain of male 5xFAD mice. in vivo overexpression has . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.